DE3853758T2 - Heterozyklische Spiroverbindungen und ihre Herstellung. - Google Patents
Heterozyklische Spiroverbindungen und ihre Herstellung.Info
- Publication number
- DE3853758T2 DE3853758T2 DE3853758T DE3853758T DE3853758T2 DE 3853758 T2 DE3853758 T2 DE 3853758T2 DE 3853758 T DE3853758 T DE 3853758T DE 3853758 T DE3853758 T DE 3853758T DE 3853758 T2 DE3853758 T2 DE 3853758T2
- Authority
- DE
- Germany
- Prior art keywords
- group
- formula
- atom
- alkyl
- chem
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/48—Oxygen atoms attached in position 4 having an acyclic carbon atom attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Hydrogenated Pyridines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25210487 | 1987-10-05 | ||
JP28629787 | 1987-11-12 | ||
JP8432788 | 1988-04-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3853758D1 DE3853758D1 (de) | 1995-06-14 |
DE3853758T2 true DE3853758T2 (de) | 1995-09-07 |
Family
ID=27304516
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE3853758T Expired - Lifetime DE3853758T2 (de) | 1987-10-05 | 1988-09-30 | Heterozyklische Spiroverbindungen und ihre Herstellung. |
Country Status (14)
Country | Link |
---|---|
US (4) | US4940795A (de) |
EP (1) | EP0311313B1 (de) |
JP (1) | JPH0236183A (de) |
KR (1) | KR970007947B1 (de) |
CN (1) | CN1036653C (de) |
AT (1) | ATE122353T1 (de) |
AU (1) | AU621559B2 (de) |
CA (1) | CA1337817C (de) |
DE (1) | DE3853758T2 (de) |
DK (1) | DK554288A (de) |
ES (1) | ES2074441T3 (de) |
GR (1) | GR3016995T3 (de) |
HU (1) | HU211687A9 (de) |
NO (1) | NO171109C (de) |
Families Citing this family (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5412096A (en) * | 1987-10-05 | 1995-05-02 | Yamanouchi Pharmaceutical Co., Ltd. | Hydrochloride salts of heterocyclic spiro compounds |
ATE122353T1 (de) * | 1987-10-05 | 1995-05-15 | Yamanouchi Pharma Co Ltd | Heterozyklische spiroverbindungen und ihre herstellung. |
US5594000A (en) * | 1989-06-21 | 1997-01-14 | Astra Ab | Spirofurane derivatives |
US5075317A (en) * | 1989-06-21 | 1991-12-24 | Fisons Corporation | Spirofurane derivatives |
US5534520A (en) * | 1990-04-10 | 1996-07-09 | Fisher; Abraham | Spiro compounds containing five-membered rings |
US5407938A (en) * | 1990-04-10 | 1995-04-18 | Israel Institute For Biological Research | Certain 1-methyl-piperidine-4-spiro-4'-(1'-3'-oxazolines) and corresponding -(1',3' thiazolines) |
US5852029A (en) * | 1990-04-10 | 1998-12-22 | Israel Institute For Biological Research | Aza spiro compounds acting on the cholinergic system with muscarinic agonist activity |
US5073560A (en) * | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
IE914238A1 (en) * | 1990-12-19 | 1992-07-01 | Fisons Corp | Novel spirofurane derivatives |
DK0590150T3 (da) * | 1991-05-15 | 1999-04-19 | Yamanouchi Pharma Co Ltd | (-)-(S)-2,8-dimethyl-3-methylen-1-oxa-8-azaspiro[4,5]decan-L-tartrat |
US5869496A (en) * | 1993-01-28 | 1999-02-09 | Merck & Co., Inc. | Spiro-substituted azacycles as tachykinin receptor antagonists |
AU6226494A (en) * | 1993-03-04 | 1994-09-26 | Pfizer Inc. | Spiroazacyclic derivatives as substance p antagonists |
JP2983141B2 (ja) * | 1993-10-06 | 1999-11-29 | 株式会社三和化学研究所 | 新規化合物及び該化合物を有効成分とする脳機能改善剤 |
NZ500643A (en) | 1997-05-30 | 2001-12-21 | Neurosearch As | Spiro-quinuclidine derivatives and their use in treating conditions responsive to nicotinic ACh receptor modulators |
US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
BR0013085A (pt) * | 1999-08-13 | 2002-04-23 | Aventis Cropscience Gmbh | Compostos espiro heterocìclicos como pesticidas |
WO2001078709A2 (en) * | 2000-04-12 | 2001-10-25 | Minerva Biotechnologies Corporation | Treatment of neurodegenerative disease |
JP2003063964A (ja) * | 2001-08-28 | 2003-03-05 | Senju Pharmaceut Co Ltd | ドライアイまたはドライアイを伴なう疾病の予防治療剤 |
JP5254616B2 (ja) | 2004-09-13 | 2013-08-07 | クロノ セラピューティクス、インコーポレイテッド | 生物学的同調性(biosynchronous)経皮的薬物送達 |
KR20080031430A (ko) * | 2005-07-26 | 2008-04-08 | 센주 세이야꾸 가부시키가이샤 | 경피적으로 흡수가능한 안과용 제제 |
EP2275095A3 (de) * | 2005-08-26 | 2011-08-17 | Braincells, Inc. | Neurogenese durch modulation des Muscarinrezeptors |
EP2258359A3 (de) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin |
US7985756B2 (en) | 2005-10-21 | 2011-07-26 | Braincells Inc. | Modulation of neurogenesis by PDE inhibition |
EP1942879A1 (de) | 2005-10-31 | 2008-07-16 | Braincells, Inc. | Gaba-rezeptor-vermittelte modulation von neurogenese |
US20100216734A1 (en) * | 2006-03-08 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis by nootropic agents |
US20070244143A1 (en) * | 2006-03-08 | 2007-10-18 | Braincells, Inc | Modulation of neurogenesis by nootropic agents |
MX2008014320A (es) * | 2006-05-09 | 2009-03-25 | Braincells Inc | Neurogenesis mediada por el receptor de 5-hidroxitriptamina. |
US20100009983A1 (en) * | 2006-05-09 | 2010-01-14 | Braincells, Inc. | 5 ht receptor mediated neurogenesis |
JP2009536669A (ja) | 2006-05-09 | 2009-10-15 | ブレインセルス,インコーポレイティド | アンジオテンシン調節による神経新生 |
ITMI20061279A1 (it) * | 2006-06-30 | 2008-01-01 | Consiglio Nazionale Ricerche | Agonisti nicotinici selettivi per il sottotipo recettoriale alfa7,procedimento per la loro preparazione e relative composizioni farmaceutiche |
JP2010502722A (ja) | 2006-09-08 | 2010-01-28 | ブレインセルス,インコーポレイティド | 4−アシルアミノピリジン誘導体を含む組み合わせ |
US20100184806A1 (en) | 2006-09-19 | 2010-07-22 | Braincells, Inc. | Modulation of neurogenesis by ppar agents |
CA2663347A1 (en) * | 2006-09-19 | 2008-03-27 | Braincells, Inc. | Ppar mediated modulation of neurogenesis |
WO2008036846A2 (en) * | 2006-09-22 | 2008-03-27 | Braincells, Inc. | Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
US7718677B2 (en) | 2007-04-02 | 2010-05-18 | Parkinson's Institute | Methods and compositions for reduction of side effects of therapeutic treatments |
KR101675174B1 (ko) * | 2009-01-26 | 2016-11-10 | 이스라엘 인스티튜트 포 바이올로지컬 리서치 | 이환형 헤테로사이클릭 스피로 화합물 |
US9034891B2 (en) | 2009-01-26 | 2015-05-19 | Israel Institute For Biological Research | Bicyclic heterocyclic spiro compounds |
US20100216805A1 (en) | 2009-02-25 | 2010-08-26 | Braincells, Inc. | Modulation of neurogenesis using d-cycloserine combinations |
ES2716049T3 (es) | 2012-07-13 | 2019-06-07 | Pain Therapeutics Inc | Un método para inhibir la fosforilación de tau |
US9433604B2 (en) | 2013-10-08 | 2016-09-06 | Pain Therapeutics Inc. | Method for inhibiting growth of cancer cells |
EP3250258A4 (de) | 2015-01-28 | 2018-09-05 | Chrono Therapeutics, Inc. | Verfahren und systeme zur wirkstofffreisetzung |
AU2018205529B2 (en) | 2017-01-06 | 2023-08-10 | Morningside Venture Investments Limited | Transdermal drug delivery devices and methods |
JP7420797B2 (ja) | 2018-05-29 | 2024-01-23 | モーニングサイド ベンチャー インベストメンツ リミテッド | 薬剤送達の方法及びシステム |
CN115124545B (zh) * | 2022-08-31 | 2023-01-03 | 南京远淑医药科技有限公司 | 一种促性腺激素释放激素受体拮抗剂中间体的合成方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3305556A (en) * | 1962-11-23 | 1967-02-21 | Pfizer & Co C | Novel hypoglycemic agents |
NL124853C (de) * | 1963-07-19 | |||
SU335944A1 (ru) * | 1970-12-15 | 1976-01-25 | Научно-исследовательский институт химии Саратовского государственного университета им.Н.Г.Чернышевского | Способ получени соединений р да 1-окса6-азаспиро(4,4)нонана |
GB1301254A (de) * | 1971-07-08 | 1972-12-29 | ||
US3784551A (en) * | 1971-07-08 | 1974-01-08 | Yoshitomi Pharmaceutical | 2-oxo-1,4-dioxa-8-azaspiro (4.5) decanes and related compounds |
US3839273A (en) * | 1971-11-13 | 1974-10-01 | Sankyo Co | N-substituted piperidine derivatives, process for preparing the same and their use as stabilizers |
SU434735A1 (ru) * | 1972-03-01 | 1975-12-15 | Научно-исследовательский институт химии Саратовского государственного университета им.Н.Г.Чернышевского | Способ получени 7-метил-(или 2,7диметил)-2-метокси- -пропионитрил1-окса-6-азаспиро-(4,4)-нонана |
SU465399A1 (ru) * | 1973-07-19 | 1975-03-30 | Научно-исследовательский институт химии при Саратовском государственном университете им.Н.Г.Чернышевского | Способ получени натриевых солей 2-метокси- -карбоксиэтил-1-окса6-азаспиро-(4,4)-нонана |
IL48452A (en) * | 1975-11-11 | 1979-07-25 | Purdue Frederick Co | Spiro (1,3-dioxolane-4,3') quinuclidines,their preparationand pharmaceutical compositions comprising them |
US4321379A (en) * | 1981-01-28 | 1982-03-23 | American Cyanamid Company | 4-Aryl-1-oxa-8-azaspiro[4,5]dec-3-en-2-ones |
SU1002294A1 (ru) * | 1981-08-14 | 1983-03-07 | Ордена Трудового Красного Знамени Институт Тонкой Органической Химии Им.А.Л.Мнджояна | 2,2-Диалкил-3-тиа-8-азаспиро/5,5/ундеканы |
EP0189370A3 (de) * | 1985-01-16 | 1988-01-27 | Sandoz Ag | Spiro-dioxolane, -dithiolane und -oxothiolane |
US4855290A (en) * | 1985-05-10 | 1989-08-08 | State Of Israel, Represented By Prime Minister's Office, Israel Institute For Biological Research | Derivatives of quinuclidine |
US4981858A (en) * | 1987-08-13 | 1991-01-01 | State Of Israel, Represented By The Prime Minister's Office, Israel Institute For Biological Research | Optical isomers |
ATE122353T1 (de) * | 1987-10-05 | 1995-05-15 | Yamanouchi Pharma Co Ltd | Heterozyklische spiroverbindungen und ihre herstellung. |
US5073560A (en) * | 1990-07-20 | 1991-12-17 | Fisons Corporation | Spiro-isoxazolidine derivatives as cholinergic agents |
-
1988
- 1988-09-30 AT AT88309095T patent/ATE122353T1/de not_active IP Right Cessation
- 1988-09-30 ES ES88309095T patent/ES2074441T3/es not_active Expired - Lifetime
- 1988-09-30 EP EP88309095A patent/EP0311313B1/de not_active Expired - Lifetime
- 1988-09-30 DE DE3853758T patent/DE3853758T2/de not_active Expired - Lifetime
- 1988-10-03 CA CA000579193A patent/CA1337817C/en not_active Expired - Fee Related
- 1988-10-04 DK DK554288A patent/DK554288A/da not_active Application Discontinuation
- 1988-10-04 JP JP63251489A patent/JPH0236183A/ja active Granted
- 1988-10-04 NO NO884406A patent/NO171109C/no unknown
- 1988-10-05 US US07/254,375 patent/US4940795A/en not_active Ceased
- 1988-10-05 AU AU23449/88A patent/AU621559B2/en not_active Ceased
- 1988-10-05 KR KR1019880012963A patent/KR970007947B1/ko not_active IP Right Cessation
- 1988-10-05 CN CN88109138A patent/CN1036653C/zh not_active Expired - Fee Related
-
1990
- 1990-01-25 US US07/470,093 patent/US5041549A/en not_active Expired - Fee Related
- 1990-01-25 US US07/470,091 patent/US4996210A/en not_active Expired - Fee Related
-
1992
- 1992-07-07 US US07/909,639 patent/USRE34653E/en not_active Expired - Lifetime
-
1995
- 1995-06-30 HU HU95P/P00638P patent/HU211687A9/hu unknown
- 1995-08-02 GR GR950402111T patent/GR3016995T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO884406D0 (no) | 1988-10-04 |
DE3853758D1 (de) | 1995-06-14 |
ATE122353T1 (de) | 1995-05-15 |
AU621559B2 (en) | 1992-03-19 |
US4996210A (en) | 1991-02-26 |
DK554288D0 (da) | 1988-10-04 |
NO171109C (no) | 1993-01-27 |
NO884406L (no) | 1989-04-06 |
US5041549A (en) | 1991-08-20 |
JPH0544948B2 (de) | 1993-07-07 |
CN1033629A (zh) | 1989-07-05 |
DK554288A (da) | 1989-05-26 |
NO171109B (no) | 1992-10-19 |
CN1036653C (zh) | 1997-12-10 |
EP0311313B1 (de) | 1995-05-10 |
KR890006649A (ko) | 1989-06-15 |
JPH0236183A (ja) | 1990-02-06 |
GR3016995T3 (en) | 1995-11-30 |
US4940795A (en) | 1990-07-10 |
KR970007947B1 (ko) | 1997-05-19 |
ES2074441T3 (es) | 1995-09-16 |
USRE34653E (en) | 1994-07-05 |
HU211687A9 (en) | 1995-12-28 |
EP0311313A2 (de) | 1989-04-12 |
AU2344988A (en) | 1989-04-06 |
CA1337817C (en) | 1995-12-26 |
EP0311313A3 (en) | 1990-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3853758T2 (de) | Heterozyklische Spiroverbindungen und ihre Herstellung. | |
ES2071681T3 (es) | Compuestos macrociclicos. | |
GR3005072T3 (de) | ||
DE69017480T2 (de) | Imidazopyridazine, ihre Herstellung und Verwendung. | |
FI911925A0 (fi) | Aminderivat. | |
MX170732B (es) | Composicion de derivados de succinimida y su uso | |
DE69411616D1 (de) | Triazolopyridazin-Derivate, ihre Herstellung und Verwendung | |
ES8706690A1 (es) | Un procedimiento para la preparacion de nuevos derivados de penem. | |
ATE115145T1 (de) | Penem-derivate, ihre herstellung und verwendung. | |
NO891609D0 (no) | Anti-hypertensive sulfonanilider. | |
AU546679B2 (en) | Hydrogenated 1,4 thiazepine (thiazine) dione derivatives | |
ATE121733T1 (de) | Imidazol-derivate und ihre verwendung als acyl coenyzm-a inhibitoren. | |
IL86665A0 (en) | Mitomycin analogs | |
KR860004040A (ko) | 3,4-디아졸 유도체의 제조방법 | |
FI903511A0 (fi) | Pyrrolo (2,1-b) tiazolderivat. | |
IL101032A0 (en) | 1,2,4-triazolo(1,5-a)pyrimidine derivatives,their preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: ASTELLAS PHARMA INC., TOKIO/TOKYO, JP |